- Home
- DGICA vs SIBN Comparison
DGICA vs SIBN Comparison
Compare DGICA & SIBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DGICA
- SIBN
- Stock Information
- Founded
- DGICA 1986
- SIBN 2008
- Country
- DGICA United States
- SIBN United States
- Employees
- DGICA N/A
- SIBN N/A
- Industry
- DGICA Property-Casualty Insurers
- SIBN Medical/Dental Instruments
- Sector
- DGICA Finance
- SIBN Health Care
- Exchange
- DGICA Nasdaq
- SIBN Nasdaq
- Market Cap
- DGICA 711.2M
- SIBN 717.0M
- IPO Year
- DGICA N/A
- SIBN 2018
- Fundamental
- Price
- DGICA $19.21
- SIBN $15.14
- Analyst Decision
- DGICA Hold
- SIBN Strong Buy
- Analyst Count
- DGICA 1
- SIBN 4
- Target Price
- DGICA $18.00
- SIBN $25.75
- AVG Volume (30 Days)
- DGICA 141.9K
- SIBN 340.7K
- Earning Date
- DGICA 10-23-2025
- SIBN 11-11-2025
- Dividend Yield
- DGICA 3.83%
- SIBN N/A
- EPS Growth
- DGICA 965.80
- SIBN N/A
- EPS
- DGICA 2.34
- SIBN N/A
- Revenue
- DGICA $993,644,532.00
- SIBN $185,262,000.00
- Revenue This Year
- DGICA $2.26
- SIBN $19.96
- Revenue Next Year
- DGICA $2.96
- SIBN $16.24
- P/E Ratio
- DGICA $8.13
- SIBN N/A
- Revenue Growth
- DGICA 3.36
- SIBN 22.93
- 52 Week Low
- DGICA $14.06
- SIBN $11.70
- 52 Week High
- DGICA $21.12
- SIBN $20.05
- Technical
- Relative Strength Index (RSI)
- DGICA 59.81
- SIBN 38.04
- Support Level
- DGICA $18.90
- SIBN $14.99
- Resistance Level
- DGICA $19.74
- SIBN $16.36
- Average True Range (ATR)
- DGICA 0.49
- SIBN 0.51
- MACD
- DGICA 0.07
- SIBN -0.09
- Stochastic Oscillator
- DGICA 77.54
- SIBN 7.94
About DGICA Donegal Group Inc.
Donegal Group Inc is an insurance holding company that offers businesses and individuals personal and commercial lines of property and casualty insurance. The company's reportable segments are its Investment function, Personal lines of insurance, and Commercial lines of insurance. Personal lines products consist mainly of homeowners and private passenger automobile policies. The Commercial lines products of its insurance subsidiaries consist mainly of commercial automobile, commercial multi-peril, and workers' compensation policies. The group mainly operates in the United States.
About SIBN SI-BONE Inc.
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.